Report Fraud About Us What We Do

Consumer News

Class Action Settlement Reached Over Infants’ Tylenol

A settlement has been reached in a class action lawsuit about the packaging and advertising of Infants’ Tylenol. The plaintiffs in the lawsuit claim that the Infants’ Tylenol packaging implies the product itself is “unique/ specially formulated for infants, when the bottle contains liquid acetaminophen of the same concentration in Children’s Tylenol, and therefore causes consumers to overpay for Infants’ Tylenol,” according to the settlement statement.

For its part, Johnson & Johnson Consumer Inc. denies all plaintiffs’ allegations stating that “the safety features of Infants’ Tylenol, especially the accompanying syringe for safe dosing of very young children, means Infants’ and Children’s are different products.”

You are included in the Settlement as a “Class Member” if you reside in the United States and purchased Infants’ Tylenol for personal or household use between October 3, 2014 and January 6, 2020.

The following are excluded from the Settlement Class: (a) Defendants, (b) the officers, directors, or employees of Defendants and their immediate families, (c) any entity in which Defendants have a controlling interest, (d) any affiliate, legal representative, heir, or assign of Defendants, (e) all federal court judges who have presided over this Action and their immediate families, (f) all persons who submit a valid request for exclusion from the Class, and (g) those who purchased Infants’ Tylenol for the purpose of resale or for use in a business setting.

The company will create a fund of up to $6.315 million. Class Members may claim $2.15 for every 1 and 2 fl. oz. bottle of Infants’ Tylenol purchased to a maximum of 7 bottles or $15.05 claimed without proof of purchase. An unlimited number of bottles may be claimed with proof of purchase.

In addition, JJCI will use reasonably diligent efforts to modify the packaging of Infants’ Tylenol and commit to educating and informing consumers, in response to inquiries and complaints to JJCI’s Consumer Care Center (CCC) relating to comparisons of Infant’s Tylenol and Children’s Tylenol, that the liquid medicine within the bottles of both Infants’ Tylenol and Children’s Tylenol contains the same concentration of liquid acetaminophen.

Do you have additional information about this settlement? Tell us in the comments below. You can also contact us for more information! Feel free to shoot us an email to Outreach@ConsiderTheConsumer.com. You can also find us on TwitterFacebook, InstagramLinkedIn, or even connect with us directly on our website!

Similarly, please check out our current list of Class Actions and Class Action Investigations, here.

Interested in articles like these? Become a subscriber below!

About the Author: Aisha K. Staggers is a writer, lecturer, political analyst and literary agent. She appears weekly for “Staggers’ State of Things” on the Dr. Vibe Show. Her work has been published by Paper Magazine, AfroPunk, The Spool, GREY Journal, MTV News, HuffPost, Blavity, Atlanta Blackstar, For Harriet, New York Review of Books and a host of other first-run publications and syndicated outlets. Find her on Twitter @AishaStaggers. For more of her work, check out her page here!

Interested in posts like these? Stay up to date with our newsletter!

No thoughts on “Class Action Settlement Reached Over Infants’ Tylenol” yet. Be the first to speak your mind!

Leave a Reply